Schonfeld Strategic Advisors’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
2022
Q4
$26.6K Sell
2022
Q3
$64K Sell
2022
Q2
$187K Sell
2022
Q1
$205K Buy
2021
Q4
$145K Sell
2021
Q3
$2.06M Buy